2011
DOI: 10.3109/02713683.2011.608240
|View full text |Cite
|
Sign up to set email alerts
|

Continuous IOP Fluctuation Recording in Normal Tension Glaucoma Patients

Abstract: Our data suggest that the continuous IOP fluctuation monitoring device is sensitive to individual IOP rhythms and to differences in such rhythms due to anti-glaucomatous drug therapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
42
0
1

Year Published

2013
2013
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 55 publications
(47 citation statements)
references
References 28 publications
4
42
0
1
Order By: Relevance
“…6,7 This new approach was validated in vitro on cannulated enucleated eyes. 6 In a small number of studies, [8][9][10][11] this new device was used in humans with glaucoma.…”
mentioning
confidence: 99%
“…6,7 This new approach was validated in vitro on cannulated enucleated eyes. 6 In a small number of studies, [8][9][10][11] this new device was used in humans with glaucoma.…”
mentioning
confidence: 99%
“…45 Cerium oxide (CeO2) nanoparticles (nanoceria particles) have a big surface area to volume ratio which is very useful for scavenging reactive oxygen intermediates (free oxygen radicals). 46 Junping Chen et al observed prevention of light damage in rodent by intravitreal injection of nanoceria particles. It indicates promising role of this nanotechnology for the management of other oxidative damaged ophthalmic conditions like macular degeneration and diabetic retinopathy.…”
Section: Cataractmentioning
confidence: 99%
“…It indicates promising role of this nanotechnology for the management of other oxidative damaged ophthalmic conditions like macular degeneration and diabetic retinopathy. 46 Cetinel S et al suggested nanotechnology for the management of cataract. They opined that nonsurgical management of cataract can be done by promoting protein solubility and/or dissolving fibrillar aggregates.…”
Section: Cataractmentioning
confidence: 99%
“…9 Patients with normal tension glaucoma 11 were monitored with the CLS off and on therapy. On the one hand these showed very unique profiles, on the other, three out of five patients…”
Section: First Applications In Humansmentioning
confidence: 99%